Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 4/2008

01.04.2008 | Mini Series: Basic research-related topics in ICM

Advances in mechanisms of repair and remodelling in acute lung injury

verfasst von: Claudia C. Dos Santos

Erschienen in: Intensive Care Medicine | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Acute respiratory distress syndrome (ARDS) is the most severe manifestation of acute lung injury (ALI). In patients who survive the acute injury the process of repair and remodelling may be an independent risk factor determining morbidity and mortality. This review explores recent advances in the field of fibroproliferative ARDS/ALI, with a special emphasis on (a) the primary contributing factors with a focus on cellular and soluble factors, and (b) mechanisms involved in repair and remodelling as they pertain to the importance of cell death, re-population, and matrix deposition.

Discussion

Factors influencing progression to fibroproliferative ARDS vs. resolution and reconstitution of the normal pulmonary parenchymal architecture are poorly understood. Determinants of persistent injury and abnormal repair and remodelling may be profoundly affected by both environmental and genetic factors. Moreover, cumulative evidence suggests that acute inflammation and fibrosis may be in part independent and interactive processes that are autonomously regulated and thus amenable to individual and specific therapy.

Conclusions

Although our current understanding of these processes is limited by the inability to accurately replicate the complex human physiology in laboratory settings, it has recently become apparent that the process of repair and remodelling begins early in the course of ARDS/ALI and may be determined by the type of pulmonary injury. Understanding the mechanisms leading to and regulating fibroproliferative changes may contribute to the development of novel early therapeutic interventions in ARDS/ALI patients.
Literatur
1.
Meduri GU (1996) The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 9:2650–2670PubMedCrossRef
2.
Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C (2007) Year in review in Intensive Care Medicine, 2006. II. Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS. Intensive Care Med 33:214–229PubMedCrossRef
3.
Marshall R, Bellingan G, Laurent G (1998) The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax 53:815–817PubMedCrossRef
4.
Bellingan GJ (2002) The pulmonary physician in critical care *6: the pathogenesis of ALI/ARDS. Thorax 57:540–546PubMedCrossRef
5.
Geiser T (2003) Mechanisms of alveolar epithelial repair in acute lung injury-a translational approach. Swiss Med Wkly 133:586–590PubMed
6.
Chapman HA (2004) Disorders of lung matrix remodeling. J Clin Invest 113:148–157PubMed
7.
Chesnutt AN, Matthay MA, Tibayan FA, Clark JG (1997) Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 156:840–845PubMed
8.
Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ, Laurent GJ (2000) Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 162:1783–1788PubMed
9.
Wesselkamper SC, Case LM, Henning LN, Borchers MT, Tichelaar JW, Mason JM, Dragin N, Medvedovic M, Sartor MA, Tomlinson CR, Leikauf GD (2005) Gene expression changes during the development of acute lung injury: role of transforming growth factor beta. Am J Respir Crit Care Med 172:1399–1411PubMedCrossRef
10.
Weinberger SE, Kelman JA, Elson NA, Young RC Jr, Reynolds HY, Fulmer JD, Crystal RG (1978) Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 89:459–466PubMed
11.
Keogh BA, Crystal RG (1982) Alveolitis: the key to the interstitial lung disorders. Thorax 37:1–10PubMedCrossRef
12.
Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D (2001) TGF-beta is a critical mediator of acute lung injury. J Clin Invest 107:1537–1544PubMedCrossRef
13.
Ichikado K, Suga M, Muranaka H, Gushima Y, Miyakawa H, Tsubamoto M, Johkoh T, Hirata N, Yoshinaga T, Kinoshita Y, Yamashita Y, Sasaki Y (2006) Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 238:321–329PubMedCrossRef
14.
Meduri GU (1993) Late adult respiratory distress syndrome. New Horiz 1:563–577PubMed
15.
Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319–328PubMedCrossRef
16.
Lovgren AK, Jania LA, Hartney JM, Parsons KK, Audoly LP, Fitzgerald GA, Tilley SL, Koller BH (2006) COX-2-derived Prostacyclin Protects Against Bleomycin-induced Pulmonary Fibrosis. Am J Physiol Lung Cell Mol Physiol 291:L144–156PubMedCrossRef
17.
Kuwano K, Hagimoto N, Nakanishi Y (2004) The role of apoptosis in pulmonary fibrosis. Histol Histopathol 19:867–881PubMed
18.
Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-de-la-Pena-Lefebvre, Brunet S, Servettaz A, Weill B, Simonneau G, Guillevin L, Boissier MC, Mouthon L (2005) Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60:765–772PubMedCrossRef
19.
Horowitz JC, Cui Z, Moore TA, Meier TR, Reddy RC, Toews GB, Standiford TJ, Thannickal VJ (2006) Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 290:L415–L425PubMedCrossRef
20.
Warburton D, Tefft D, Mailleux A, Bellusci S, Thiery JP, Zhao J, Buckley S, Shi W, Driscoll B (2001) Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny? Am J Respir Crit Care Med 164:S59–S62PubMed
21.
Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB (2003) Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313–317PubMedCrossRef
22.
Douglas IS, Diaz DV, Winn RA, Voelkel NF (2006) Beta-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol 34:274–285PubMedCrossRef
23.
Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR (2004) Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 164:577–588PubMed
24.
Borthwick DW, Shahbazian M, Krantz QT, Dorin JR, Randell SH (2001) Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 24:662–670PubMed
25.
Porter RM, Lane EB (2003) Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 19:278–285PubMedCrossRef
26.
Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128:5181–5188PubMed
27.
Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, Suzuki T, Sasaki H (2004) Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 172:1266–1272PubMed
28.
Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145–152PubMedCrossRef
29.
Gomperts BN, Belperio JA, Rao PN, Randell SH, Fishbein MC, Burdick MD, Strieter RM (2006) Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol 176:1916–1927PubMed
30.
31.
Li HP, Li X, He GJ, Yi XH, Kaplan AP (2004) The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats. Respirology 9:25–32PubMedCrossRef
32.
Kuwano K, Hagimoto N, Hara N (2001) Molecular mechanisms of pulmonary fibrosis and current treatment. Curr Mol Med 1:551–573PubMedCrossRef
33.
Wang HC, Shun CT, Hsu SM, Kuo SH, Luh KT, Yang PC (2002) Fas/Fas ligand pathway is involved in the resolution of type II pneumocyte hyperplasia after acute lung injury: evidence from a rat model. Crit Care Med 30:1528–1534PubMedCrossRef
34.
Budinger GR, Chandel NS (2001) The role of cell suicide or apoptosis in the pathophysiology of acute lung injury. Intensive Care Med 27:1091–1093PubMedCrossRef
35.
Wang R, Zagariya A, Ang E, Ibarra-Sunga O, Uhal BD (1999) Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am J Physiol 277:L1245–L1250PubMed
36.
Hagimoto N, Kuwano K, Inoshima I, Yoshimi M, Nakamura N, Fujita M, Maeyama T, Hara N (2002) TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168:6470–6478PubMed
37.
Sookhai S, Wang JJ, McCourt M, Kirwan W, Bouchier-Hayes D, Redmond P (2002) A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 235:285–291PubMedCrossRef
38.
Matute-Bello G, Lee JS, Liles WC, Frevert CW, Mongovin S, Wong V, Ballman K, Sutlief S, Martin TR (2005) Fas-mediated acute lung injury requires fas expression on nonmyeloid cells of the lung. J Immunol 175:4069–4075PubMed
39.
Braude S, Apperley J, Krausz T, Goldman JM, Royston D (1985) Adult respiratory distress syndrome after allogeneic bone-marrow transplantation: evidence for a neutrophil-independent mechanism. Lancet 1:1239–1242PubMedCrossRef
40.
Winn R, Maunder R, Chi E, Harlan J (1987) Neutrophil depletion does not prevent lung edema after endotoxin infusion in goats. J Appl Physiol 62:116–121PubMed
41.
Clark JG, Kuhn C 3rd (1982) Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis 126:737–739PubMed
42.
Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, Litvinov SV, van Krieken JH, de Boer WI, Hiemstra PS (2002) Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 72:167–174PubMed
43.
Aarbiou J, Verhoosel RM, van Wetering S, de Boer WI, van Krieken JH, Litvinov SV, Rabe KF, Hiemstra PS (2004) Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 30:193–201PubMedCrossRef
44.
MacGregor IR, Perrie AM, Donnelly SC, Haslett C (1997) Modulation of human endothelial thrombomodulin by neutrophils and their release products. Am J Respir Crit Care Med 155:47–52PubMed
45.
Shih JY, Yang SC, Yu CJ, Wu HD, Liaw YS, Wu R, Yang PC (1997) Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 156:1453–1457PubMed
46.
Rose MC, Voynow JA (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:245–278PubMedCrossRef
47.
Reynolds HY (2005) Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s. Am J Respir Crit Care Med 171:98–102PubMedCrossRef
48.
Shimabukuro DW, Sawa T, Gropper MA (2003) Injury and repair in lung and airways. Crit Care Med 31:S524–S531PubMedCrossRef
49.
Dos Santos CC, Slutsky AS (2006) The contribution of biophysical lung injury to the development of biotrauma. Annu Rev Physiol 68:585–618PubMedCrossRef
50.
Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C, Schimmer RC (2005) Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res 6:61PubMedCrossRef
51.
Elder A, Johnston C, Gelein R, Finkelstein J, Wang Z, Notter R, Oberdorster G (2005) Lung inflammation induced by endotoxin is enhanced in rats depleted of alveolar macrophages with aerosolized clodronate. Exp Lung Res 31:527–546PubMedCrossRef
52.
Warner AE (1996) Pulmonary intravascular macrophages. Role in acute lung injury. Clin Chest Med 17:125–135PubMedCrossRef
53.
O'Dea KP, Young AJ, Yamamoto H, Robotham JL, Brennan FM, Takata M (2005) Lung-marginated monocytes modulate pulmonary microvascular injury during early endotoxemia. Am J Respir Crit Care Med 172:1119–1127PubMedCrossRef
54.
Olman MA, White KE, Ware LB, Simmons WL, Benveniste EN, Zhu S, Pugin J, Matthay MA (2004) Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression. J Immunol 172:2668–2677PubMed
55.
Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA (1986) Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77:645–648PubMedCrossRef
56.
Portnoy J, Pan T, Dinarello CA, Shannon JM, Westcott JY, Zhang L, Mason RJ (2006) Alveolar type II cells inhibit fibroblast proliferation: role of IL-1alpha. Am J Physiol Lung Cell Mol Physiol 290:L307–L316PubMedCrossRef
57.
Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N (2006) Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-{kappa}B Activation and a Reciprocal Suppression of TGF-beta Signal Pathway. J Immunol 176:5598–5606PubMed
58.
Belperio JA, DiGiovine B, Keane MP, Burdick MD, Ying XY, Ross DJ, Lynch JP 3rd, Kunkel SL, Strieter RM (2002) Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. Transplantation 73:591–599PubMedCrossRef
59.
Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J (2001) Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107:1529–1536PubMedCrossRef
60.
Bonner JC, Rice AB, Ingram JL, Moomaw CR, Nyska A, Bradbury A, Sessoms AR, Chulada PC, Morgan DL, Zeldin DC, Langenbach R (2002) Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 161:459–470PubMed
61.
Moore BB, Peters-Golden M, Christensen PJ, Lama V, Kuziel WA, Paine R 3rd, Toews GB (2003) Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am J Physiol Lung Cell Mol Physiol 284:L342–L349PubMed
62.
Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M (1995) Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 95:1861–1868PubMedCrossRef
63.
Moore BB, Ballinger MN, White ES, Green ME, Herrygers AB, Wilke CA, Toews GB, Peters-Golden M (2005) Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. J Immunol 174:5644–5649PubMed
64.
Zhu YK, Liu XD, Skold MC, Umino T, Wang H, Romberger DJ, Spurzem JR, Kohyama T, Wen FQ, Rennard SI (2001) Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE (2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol 25:245–253PubMed
65.
Bartram U, Speer CP (2004) The role of transforming growth factor beta in lung development and disease. Chest 125:754–765PubMedCrossRef
66.
Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD (2003) The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol 28:499–503PubMedCrossRef
67.
Nishioka A, Ogawa Y, Mima T, Jin YJ, Sonobe H, Kariya S, Kubota K, Yoshida S, Ueno H (2004) Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector. Int J Radiat Oncol Biol Phys 58:1235–1241PubMed
68.
Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA (2000) Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 97:1778–1783PubMedCrossRef
69.
Dhainaut JF, Charpentier J, Chiche JD (2003) Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 31:S258–S264PubMedCrossRef
70.
Matthay MA, Robriquet L, Fang X (2005) Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc Am Thorac Soc 2:206–213PubMedCrossRef
71.
Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A (1998) Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med 158:3–11PubMed
72.
Zimmerman GA, Albertine KH, Carveth HJ, Gill EA, Grissom CK, Hoidal JR, Imaizumi T, Maloney CG, McIntyre TM, Michael JR, Orme JF, Prescott SM, Topham MS (1999) Endothelial activation in ARDS. Chest 116:18S–24SPubMedCrossRef
73.
Sadikot RT, Jansen ED, Blackwell TR, Zoia O, Yull F, Christman JW, Blackwell TS (2001) High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice. Am J Respir Crit Care Med 164:873–878PubMed
74.
Menezes SL, Bozza PT, Neto HC, Laranjeira AP, Negri EM, Capelozzi VL, Zin WA, Rocco PR (2005) Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol 98:1777–1783PubMedCrossRef
75.
Santos FB, Nagato LK, Boechem NM, Negri EM, Guimaraes A, Capelozzi VL, Faffe DS, Zin WA, Rocco PR (2006) Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol 100:98–106PubMedCrossRef
76.
Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419–424PubMedCrossRef
77.
Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232–237PubMedCrossRef
78.
Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF (2000) Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 106:1341–1350PubMedCrossRef
79.
Sisson TH, Hanson KE, Subbotina N, Patwardhan A, Hattori N, Simon RH (2002) Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol 283:L1023–L1032PubMed
80.
Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA (2000) The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157:177–187PubMed
81.
Blanc-Brude OP, Archer F, Leoni P, Derian C, Bolsover S, Laurent GJ, Chambers RC (2005) Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res 304:16–27PubMedCrossRef
82.
Howell DC, Goldsack NR, Marshall RP, McAnulty RJ, Starke R, Purdy G, Laurent GJ, Chambers RC (2001) Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 159:1383–1395PubMed
83.
Suzuki K, Gabazza EC, Hayashi T, Kamada H, Adachi Y, Taguchi O (2004) Protective role of activated protein C in lung and airway remodeling. Crit Care Med 32:S262–S265PubMedCrossRef
84.
Jesmin S, Gando S, Matsuda N, Sakuma I, Kobayashi S, Sakuraya F, Hattori Y (2004) Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost 92:966–979PubMed
85.
Wei Y, Eble JA, Wang Z, Kreidberg JA, Chapman HA (2001) Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell 12:2975–2986PubMed
86.
87.
Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173–1179PubMedCrossRef
88.
Bai KJ, Spicer AP, Mascarenhas MM, Yu L, Ochoa CD, Garg HG, Quinn DA (2005) The role of hyaluronan synthase 3 in ventilator-induced lung injury. Am J Respir Crit Care Med 172:92–98PubMedCrossRef
89.
Fourrier F, Chopin C, Wallaert B, Mazurier C, Mangalaboyi J, Durocher A (1985) Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 87:191–195PubMedCrossRef
90.
Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ (2002) Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166:646–650PubMedCrossRef
91.
Ward WF, Molteni A, Ts'ao CH, Hinz JM (1990) Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 19:1405–1409PubMed
92.
Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD (2000) Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 279:L143–L151PubMed
93.
Ward WF, Molteni A, Ts'ao CH, Kim YT, Hinz JM (1992) Radiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys 22:623–625PubMed
94.
Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E, Deshmukh S, Chaudhary G, Baraboutis J, Filippatos G, Uhal BD (1999) Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 276:L885–L889PubMed
95.
Marshall RP, McAnulty RJ, Laurent GJ (2000) Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161:1999–2004PubMed
96.
Weber H, Taylor DS, Molloy CJ (1994) Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest 93:788–798PubMedCrossRef
97.
Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, Laurent GJ (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L156–L164PubMedCrossRef
98.
Negri EM, Hoelz C, Barbas CS, Montes GS, Saldiva PH, Capelozzi VL (2002) Acute remodeling of parenchyma in pulmonary and extrapulmonary ARDS. An autopsy study of collagen-elastic system fibers. Pathol Res Pract 198:355–361PubMedCrossRef
Metadaten
Titel
Advances in mechanisms of repair and remodelling in acute lung injury
verfasst von
Claudia C. Dos Santos
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 4/2008
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0963-x

Weitere Artikel der Ausgabe 4/2008

Intensive Care Medicine 4/2008 Zur Ausgabe

Mini Series: Basic research-related topics in ICM

Effects of mechanical ventilation on the extracellular matrix

Pediatric Original

A prospective study of phrenic nerve damage after cardiac surgery in children

Original

The human response to infection is associated with distinct patterns of interleukin 23 and interleukin 27 expression

Brief Report

Assessment of stroke volumeindex with three different bioimpedance algorithms: lack of agreement compared to thermodilution

Announcements

Announcement

Original

Effects of systemic antibiotic therapy on bacterial persistence in the respiratory tract of mechanically ventilated patients

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise